HK1037976A1 - Agents with an antidepressive effect. - Google Patents

Agents with an antidepressive effect.

Info

Publication number
HK1037976A1
HK1037976A1 HK01108876A HK01108876A HK1037976A1 HK 1037976 A1 HK1037976 A1 HK 1037976A1 HK 01108876 A HK01108876 A HK 01108876A HK 01108876 A HK01108876 A HK 01108876A HK 1037976 A1 HK1037976 A1 HK 1037976A1
Authority
HK
Hong Kong
Prior art keywords
agents
antidepressive effect
antidepressive
effect
Prior art date
Application number
HK01108876A
Other languages
English (en)
Inventor
Jerzy Maj
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HK1037976A1 publication Critical patent/HK1037976A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK01108876A 1998-07-07 2001-12-19 Agents with an antidepressive effect. HK1037976A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (de) 1998-07-07 1999-07-02 Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum

Publications (1)

Publication Number Publication Date
HK1037976A1 true HK1037976A1 (en) 2002-03-01

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108876A HK1037976A1 (en) 1998-07-07 2001-12-19 Agents with an antidepressive effect.

Country Status (33)

Country Link
US (1) US6255329B1 (cs)
EP (1) EP1093369B1 (cs)
JP (1) JP2002520273A (cs)
KR (1) KR100557692B1 (cs)
CN (1) CN1230168C (cs)
AR (1) AR019896A1 (cs)
AT (1) ATE228365T1 (cs)
AU (1) AU762128B2 (cs)
BG (1) BG64972B1 (cs)
BR (1) BR9911768A (cs)
CA (1) CA2336833C (cs)
CZ (1) CZ294087B6 (cs)
DE (2) DE19830201A1 (cs)
DK (1) DK1093369T3 (cs)
EA (1) EA003142B1 (cs)
EE (1) EE04296B1 (cs)
ES (1) ES2183583T3 (cs)
HK (1) HK1037976A1 (cs)
HU (1) HUP0103922A3 (cs)
ID (1) ID27776A (cs)
IL (1) IL140603A0 (cs)
MY (1) MY117969A (cs)
NO (1) NO20010064L (cs)
NZ (1) NZ509729A (cs)
PL (1) PL195043B1 (cs)
PT (1) PT1093369E (cs)
RS (1) RS49795B (cs)
SK (1) SK284923B6 (cs)
TR (1) TR200100146T2 (cs)
TW (1) TW592698B (cs)
WO (1) WO2000002542A2 (cs)
YU (1) YU401A (cs)
ZA (1) ZA200100090B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
EP2305252A1 (en) * 2001-12-11 2011-04-06 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
CA2554616A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
CA2619217A1 (en) * 2005-08-15 2007-02-22 University Of Virginia Patent Foundation Neurorestoration with r(+) pramipexole
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
CA2652251A1 (en) 2006-05-16 2007-11-29 Knopp Neurosciences, Inc. Compositions of r(+) and s(-) pramipexole and methods for using the same
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
WO2008113056A2 (en) 2007-03-14 2008-09-18 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
CA2735934C (en) 2008-09-05 2014-01-07 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
EP2424539A4 (en) * 2009-04-30 2012-09-19 Supernus Pharmaceuticals Inc PROCESS FOR TREATING DEPRESSION
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
MX356727B (es) 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
CN105764507B (zh) 2013-07-12 2019-07-19 诺普生物科学有限责任公司 治疗升高的嗜酸性粒细胞和/或嗜碱性粒细胞的水平
ES2871556T3 (es) 2013-08-13 2021-10-29 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de la urticaria crónica
ES2813674T3 (es) 2013-08-13 2021-03-24 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
US11160809B2 (en) * 2017-04-10 2021-11-02 Chase Therapeutics Corporation NK1-antagonist combination and method for treating synucleinopathies
BR112019028034A2 (pt) 2017-06-30 2020-07-07 Chase Therapeutics Corporation composições de antagonista de nk-1 e métodos para uso no tratamento da depressão
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
ATE45735T1 (de) * 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
TR199801929T2 (xx) * 1996-03-29 1998-12-21 Pfizer Inc. Benzil(iden)-laktam t�revleri, bunlar�n 5-HT1A resept�rlerinin (ant)agonistler olarak kullan�mlar� .
CA2273809A1 (en) * 1996-12-02 1998-06-11 Merck Sharp & Dohme Limited Use of nk-1 receptor antagonists for treating movement disorders
EP1047436B1 (en) * 1998-01-13 2009-10-21 Synchroneuron, LLC N-acetylhomotaurinates for use in treating hyperkinesias

Also Published As

Publication number Publication date
ID27776A (id) 2001-04-26
CZ294087B6 (cs) 2004-10-13
EA003142B1 (ru) 2003-02-27
ATE228365T1 (de) 2002-12-15
WO2000002542A2 (de) 2000-01-20
BG105112A (en) 2001-10-31
SK112001A3 (en) 2001-10-08
PL345842A1 (en) 2002-01-14
CZ200177A3 (en) 2001-06-13
CN1308533A (zh) 2001-08-15
AR019896A1 (es) 2002-03-20
IL140603A0 (en) 2002-02-10
HUP0103922A3 (en) 2002-08-28
NO20010064L (no) 2001-03-02
CN1230168C (zh) 2005-12-07
CA2336833C (en) 2008-09-23
ZA200100090B (en) 2002-04-04
TR200100146T2 (tr) 2001-07-23
EE200100014A (et) 2002-06-17
EA200100084A1 (ru) 2001-08-27
DE19830201A1 (de) 2000-01-13
BG64972B1 (bg) 2006-11-30
ES2183583T3 (es) 2003-03-16
HUP0103922A2 (hu) 2002-03-28
RS49795B (sr) 2008-06-05
EP1093369A2 (de) 2001-04-25
NO20010064D0 (no) 2001-01-05
MY117969A (en) 2004-08-30
TW592698B (en) 2004-06-21
BR9911768A (pt) 2001-04-03
KR100557692B1 (ko) 2006-03-07
EP1093369B1 (de) 2002-11-27
JP2002520273A (ja) 2002-07-09
YU401A (sh) 2003-10-31
CA2336833A1 (en) 2000-01-20
KR20010079491A (ko) 2001-08-22
SK284923B6 (sk) 2006-02-02
US6255329B1 (en) 2001-07-03
EE04296B1 (et) 2004-06-15
AU762128B2 (en) 2003-06-19
DK1093369T3 (da) 2002-12-16
DE59903556D1 (de) 2003-01-09
PL195043B1 (pl) 2007-08-31
NZ509729A (en) 2003-06-30
PT1093369E (pt) 2003-03-31
WO2000002542A3 (de) 2000-06-22
AU5030399A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
HK1037976A1 (en) Agents with an antidepressive effect.
ZA996185B (en) Sulfanylsilanes.
HK1041947A1 (en) Scheduling instructions with different latencies.
ZA200005136B (en) Dihydropyrimides.
ZA995771B (en) Cylinder lock-key-combination.
ZA991951B (en) Compound and its use.
ZA99254B (en) Benzosulfone derivatives.
ZA200000865B (en) Dicarboalkoxy dioxolanes.
HK1022379A1 (en) Electrochemical device.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA991550B (en) Cyclohexanediole derivatives.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA993123B (en) Trisresorcinyltriazines.
HK1019870A1 (en) Component carrying device.
IL130598A0 (en) 3-aminocarbonyl-3-aminothiocarbonyl-substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect
HK1021879A1 (en) Carrying case.
ZA993225B (en) Cooling reservoir.
HK1028588A1 (en) Case.
GB2344342B (en) I.S Machine
ZA996936B (en) Railbreak indicating arrangement.
ZA991761B (en) New agent.
ZA99712B (en) An attachment member.
ZA993690B (en) Dam-scraper.
IT1304351B1 (it) Propulsore ad idrogetto.
ZA991187B (en) Device.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090702